In summary, in the present study, we demonstrate that CPVT-associated RyR2 G357S mutation increases the SOICR activity by reducing the thresholds for SOICR activation and termination and increasing the fractional Ca2+ release. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.